Skip to main content
Premium Trial:

Request an Annual Quote

Quidel Reports Preliminary Q4, FY2014 Revenues

NEW YORK (GenomeWeb) – Quidel said today that it expects revenues in the range of $63 million to $64 million for the fourth quarter and $182 million to $183 million for full-year 2014.

The preliminary results are based on management's initial analysis of operations for the quarter ended Dec. 31, Quidel said in a filing with the US Securities and Exchange Commission.

The Q4 revenue projection would represent a 26 percent to 28 percent increase year over year. On average, analysts were estimating $57.3 million in revenues for the company in Q4.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.